MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Genetics"

  • 2025 International Congress

    Unraveling NKX2-1-related disorders: clinical, genetic, and neuroimaging insights from a global cohort

    JD. Ortigoza-Escobar, L. Nou-Fontanet, C. Ravelli, S. Balsells Mejia, E. Roman Schiffels, A. Innocenti, B. Villafuerte, A. Salazar, V. Quiroz, A. Sariego Jamardo, G. Bonato, A. Díaz-Gomez, A. Afenjar, C. Vilain, P. Dumke Dasilva, D. Garcia-Navas Nuñez, M. Krygier, MJ. Molnar, L. Milanowski, K. Ounap, M. Pauni, R. Borie, P. Vega, M. Villamil, S. Yilmaz, D. Zádori, M. Zawadzka, TS. Barakat, N. Sebastian, D. Natera Debenito, L. Soliani, CM. de Gusmao, G. Garone, N. Specchio, M. Carecchio, JC. Moreno, F. Magrinelli, D. Ebrahimi-Fakhari, C. Castiglioni, M. Kurian, JN. Carvalho, R. Pons, E. Flamand-Roze, D. Doummar (Barcelona, Spain)

    Objective: To analyze the clinical spectrum, genotype-phenotype correlations, and prognostic factors in NKX2-1-related disorders (NKX2-1-RD) through a multicenter study, providing insights for improved diagnosis and…
  • 2025 International Congress

    Co-occurrence of Spinal Muscular Atrophy Type 2 and Huntington’s Disease

    U. Agarwal, S. Fu, Y. Wang, B. Bulica (Detroit, USA)

    Objective: To describe a unique case of co-occurring SMA2 and HD in a patient. Background: Huntington’s Disease (HD) is an autosomal dominant neurodegenerative disorder caused…
  • 2025 International Congress

    Huntington’s Disease: Overview from 20 Years of a Single-Center Experience

    M. Tsalta-Mladenov, M. Levkova, M. Hachmeriyan, L. Angelova (Varna, Bulgaria)

    Objective: This study evaluates patient data from individuals with Huntington’s disease who attended our single tertiary center. Background: Huntington’s disease is an inherited neurodegenerative disorder…
  • 2025 International Congress

    Burden of Non-Motor Manifestations in Huntington’s disease patients – A cross-sectional study in a teaching hospital in India.

    M. Prathyusha, D. Radhakrishnan (New Delhi, India)

    Objective: Primary objective:- 1) To study the prevalence of non-motor manifestations in Huntington disease.2) To study the correlation between non motor symptoms and Quality of lifeSecondary…
  • 2025 International Congress

    Dentatorubral–Pallidoluysian Atrophy (DRPLA) : A case series of nine patients from western India

    K. Bavdhankar, P. Agarwal, N. Jain, S. Kothari, A. Soni, S. Kharat, A. Shah, S. Jagtap (Mumbai, India)

    Objective: To study the clinicoradiological and genetic profile of confirmed Dentatorubral–Pallidoluysian Atrophy (DRPLA) cases in Western India Background: DRPLA is a hereditary disease caused due to trinucleotide repeat…
  • 2025 International Congress

    A RNF213 truncating variant causes an autosomal dominant disorder with brainstem and basal ganglia lesions and a Huntington-like phenotype

    R. Bovenzi, F. Shen, IJ. Keller Sarmiento, BI. Bustos, L. Kinsley, J. Nichols, D. Krainc, NE. Mencacci (Chicago, USA)

    Objective: To report a novel stop-gain variant in the RNF213 gene in two individuals, a father and son, presenting with variable neurologic presentations and similar…
  • 2025 International Congress

    Huntington-like disease type 2 caused by a JPH3 repeat expansion in a patient from Iraq

    A. Currie, E. Kugelmann, K. Lashinger, N. Mcfarland (Gainesville, USA)

    Objective: To report the case of a patient from Iraq with a Huntington disease-like phenotype who was found to have a heterozygous trinucleotide repeat expansion…
  • 2025 International Congress

    Chorea-acanthocytosis in Puerto Rico: A Case Series

    E. Pérez-Luciano, C. Chapel-Crespo, D. Lozada-Figueroa, I. Pita-García, L. Surillo-Dahdah (Ponce, Puerto Rico)

    Objective: To describe three unrelated cases of Chorea-acanthocytosis (ChAc) from Puerto Rico, featuring heterozygous and homozygous pathogenic variants Background: ChAc, a rare autosomal recessive neurodegenerative…
  • 2025 International Congress

    Chorea,dystonia, and tics:lessons learned from the clinical pattern associated with VPS13A disease

    H. Saglam, J. Frey (Morgantown, USA)

    Objective: To highlight clinical manifestations of VPS13A disease Background: VPS13A disease causes motor and neuropsychiatric symptoms including dystonia, chorea, tics, and cognitive decline, but can…
  • 2025 International Congress

    Compound Heterozygous VPS13A Variants in a Chilean Chorea-Acanthocytosis Patient

    P. Meza Castro, P. Saffie Awad, E. Fernández Toledo (Concepción, Chile)

    Objective: To present a clinical case of a Chilean ChAC patient with a new compound heterozygous VPS13A variant. Background: Neuroacanthocytosis is a group of genetic…
  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley